Lewis H. Titterton Jr., Anixa Biosciences stock purchase

Director, SEC Form 4, filed on July 20, 2026
$41,64012,000 shares, average $3.47
Transaction date
July 20, 2026
Shares held after
986,967Direct ownership
Change in holding
+1.23%From the transactions in the filing
Filing rows
1All open market

Price context

ANIX daily close, Apr 20 to October 26, 2026
$3.75$2.35
Daily close
Purchase
Trade average $3.47
Transaction price
$3.47Weighted average
Close on trade date
$3.46July 20, 2026
Latest close
$2.93October 26, 2026
Since the trade
−15.56%vs the trade average

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Purchase
Common stockDirect
12,000
$3.47
$41,640
986,967

Recent filings at Anixa Biosciences

Full history
PersonTransactionAmount or sharesDate
Lewis H. Titterton Jr.Director
Purchase
$23,840
Amit KumarCEO
Purchase
$21,760
Michael CatelaniCFO
Purchase
$15,620
Amit KumarCEO
Purchase
$19,460
Arnold M. BaskiesDirector
Purchase
$13,800
Lewis H. Titterton Jr.Director
Purchase
$27,300
Amit KumarCEO
Purchase
$13,800
Amit KumarCEO
Purchase
$8,250